Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;16(11):1048-54.
doi: 10.1111/dom.12308. Epub 2014 May 22.

Mitochondrial Target of Thiazolidinediones


Mitochondrial Target of Thiazolidinediones

J R Colca et al. Diabetes Obes Metab. .


Insulin-sensitizing thiazolidinediones exert a pleiotropic pharmacology with therapeutic potential in a number of disease states ranging from metabolic syndrome and diabetes to neurodegeneration and cancer. A growing understanding of their mechanism of action, working from the site of their binding in the mitochondrion, provides insight into the mechanism of action of the insulin sensitizers and the reasons for their pleiotropic pharmacology. This review helps to frame the direction of future work that should be helpful in setting a new direction for the discovery and development of new, more useful therapeutic agents for metabolic disease.

Keywords: diabetes mellitus; insulin resistance; thiazolidinediones.

Similar articles

See all similar articles

Cited by 3 articles

LinkOut - more resources